NovoCure Shares Surge 29% on Q2 Results, 2026 Forecast Raised
NovoCure Limited climbed 29.3% on Thursday following record quarterly sales and an improved outlook for 2026. Shares stood at $20.13 as of 1:15 p.m. EDT and reached $20.53, a fresh 52-week high. The Nasdaq regular session continued.
